Gain Access to exclusive preclinical content.
Complete the form below to gain access to mattis aliquet nunc aliquam tempor. We’ll assign a user name and password, then send you a link. Thanks!

Get Access Register

EXCLUSIVE PRECLINICAL CONTENT.
You must log in to access content on this page. Or click here to request access.
Novel Keap-Nrf2 Protein-Protein Interaction Inhibitor UBE-1099 Ameliorates the Severity of Experimental Alport Syndrome

Shota Kaseda, Mary Ann Suico, Sayaka Ogi, Hidetoshi Sunamoto,Hirohiko Fukiya, Futoshi Nara, Tsuyoshi Shuto, Kazuhiro Onuma, Hirofumi Kai, "Novel Keap-Nrf2 Protein-Protein Interaction Inhibitor UBE-1099 Ameliorates the Severity of Experimental Alport Syndrome", Am. Soc. Nephrol. Kidney Week Abstract Supplement: PO1302 2021.